triple-negative breast cancer

Triple-negative breast cancer is a subtype of breast cancer characterized by the absence of estrogen, progesterone, and HER2 receptors; it tends to be more aggressive and less responsive to traditional hormone-targeted therapies; recent findings indicate that this cancer type may rely on omega-6 linoleic acid and FABP5 to activate mTORC1, driving its growth; identifying unique vulnerabilities in triple-negative breast cancer could lead to improved treatment strategies.